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Background: Acute respiratory tract infections (ARI) present a significant morbidity and pose a global
health burden. Patients are frequently treated with antibiotics although ARI are most commonly caused
by virus, strengthening the need for improved diagnostic methods.
Objectives: Detect viral and bacterial RNA in nasopharyngeal aspirates (NPA) from children aged 6–23
months with ARI using nCounter.
Study design: A custom-designed nCounter probeset containing viral and bacterial targets was tested in
NPA of ARI patients.
Results: Initially, spiked control viral RNAs were detectable in ≥6.25ng input RNA, indicating absence of
inhibitors in NPA. nCounter applied to a larger NPA sample (n=61) enabled the multiplex detection of
different pathogens: RNA viruses Parainfluenza virus (PIV 1–3) and RSV A-B in 21%, Human metapneu-
movirus (hMPV) in 5%, Bocavirus (BoV), CoV, Influenza virus (IV) A in 3% and, Rhinovirus (RV) in 2% of
samples, respectively. RSV A-B was confirmed by Real Time PCR (86.2–96.9% agreement). DNA virus (AV)
wasdetected at RNA level, reflecting viral replication, in 10%of samples. Bacterial transcripts from Staphy-
lococcus aureus, Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Mycoplasma
pneumoniae and Chlamydophila pneumoniae were detected in 77, 69, 26, 8, 3 and 2% of samples, respec-
tively.
Conclusion: nCounter is robust and sensitive for the simultaneous detection of viral (both RNA and DNA)
and bacterial transcripts in NPA with low RNA input (<10ng). This medium-throughput technique will
increase our understanding of ARI pathogenesis and may provide an evidence-based approach for the
targeted and rational use of antibiotics in pediatric ARI.
© 2015 Elsevier B.V. All rights reserved.
1. Background
Acute respiratory tract infection (ARI) accounts for both high
mortality and morbidity in children <5 years old [1]. In develop-
ing countries, 75% of all acute morbidities were assigned as ARI but
identification of the etiological agent in these cases is not com-
mon [2]. Upper respiratory tract infections are most commonly
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caused by virus and only 10% of cases are attributed to bacteria
[3]; nonetheless, most patients are treated with antibiotics [1].
Respiratory viruses can be diagnosed by culture, antibody-
basedandnucleic acid–baseddetectionmethods. Polymerase chain
reaction (PCR) is the most widespread technique for pathogen
identification [4]; however, simultaneous detection of different
pathogens by multiplex PCR demands reaction standardization.
To this end, nCounter (NanoString Technologies), a digital mRNA
expression profiling method, can overcome these drawbacks: it
identifies genetic material using two probes, one anchored to the
genetic material and the other anchored to a singular bar code
that identifies the target by specific hybridization. Upon bar code
http://dx.doi.org/10.1016/j.jcv.2015.06.005
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K.F. Fukutani et al. / Journal of Clinical Virology 69 (2015) 190–196 191
Fig. 1. Quantification of the positive control RNAs by nCounter.
Number of counts for exogenous positive control RNAs (background-subtracted) plotted against the different concentrations tested (0.125–128 fM). The correlation coeffi-
cients (R2 values) of a linear fit to the mean (n=61) are indicated for the entire concentration range tested and, in the insert, for the concentrations <0.25 fM.
hybridization, presence and frequency of the target is revealed and
multiple barcodes in the same reaction allow multiplex analysis
[5].
2. Objectives
We designed a codeset for quantification of viral (RV, RSV A
and B, IV A and B, PIV (types 1 and 3), AV (types 2 and 5), hMPV,
BoV, CoV) and bacterial (Streptococcus pneumoniae, Haemophilus
influenzae,Moraxella catarrhalis, Staphylococcus aureus,Mycoplasma
pneumoniae and Chlamydia pneumoniae) transcripts in one mul-
tiplex reaction employing nasopharingeal aspirates (NPA) from
children presenting ARI.
3. Study design
3.1. Clinical samples
Our study complied with the guidelines of the Declaration of
Helsinki and was approved by the institutional review board of
the Universidade Federal da Bahia (UFBA) (#067/2009). Written
informed consent was obtained from all legal guardians. This was
a prospective cohort study involving a sample of children aged
6–23 months, seen at UFBA’s Emergency Unit between 2009 and
2011 [6]. Community-dwelling patients fulfilling inclusion criteria
(fever, cough, sneeze or nasal obstruction for a period up to seven
days and without previous episode of wheezing) were enrolled
and NPA were collected. Control samples (nasopharyngeal wash)
were obtained from individuals (n=7) undergoing routine outpa-
tient visits. After collection, samples were place in Nuclisens lysis
buffer (Biomerieux) and frozen at −70 ◦C.
3.2. RNA extraction and nCounter analysis
Viral and bacterial detection in NPA was performed using
nCounter transcriptomic analysis (NanoString Technologies),
allowing us to simultaneously assay for viral and bacterial targets.
Total RNA (10–50ng), obtained from a subset of randomly selected
NPAs, was extracted using Qiagenı´s RNEasy, following manu-
facturerı´s instructions, and was subsequently hybridized against
probes targeting RV, RSVA-B, IV A-B, PIV (types 1 and 3), AV
(types 2 and 5), hMPV, BoV and CoV (229A and OC43), S. pneu-
moniae, H. influenzae, M. catarrhalis, S. aureus, C. pneumoniae and M.
pneumoniae(Supplementary Table 1), synthesized by NanoString
Technologies. Hybridization was also performed with control viral
and bacterial RNA pools [kindly donated by K. Bruyninckx, UZ Leu-
ven], in three different concentrations (6.25, 12.5 and 25ng for viral
RNA and 1.5, 3 and 6ng for bacterial RNA).
3.3. Real-Time PCR
RSV A and B were independently quantified by Real-Time PCR,
as described [7].
3.4. Data analysis
Raw data were pre-processed using both nSolver 2.0 software
(Nanostring Technologies) and the NanoStringNorm R package
[8]. Preprocessing sequentially corrects for three factors: techni-
cal variation, background and sample content. First, using a set of
exogenous positive control RNAs present in each sample (see also
Fig. 1), technical variation is accounted for by adjusting the counts
in each sample to the geometric mean of counts for positive con-
trol counts in all samples. Subsequently, a background correction
is performed by subtracting the maximum count value of the neg-
ative control probes in a sample from each probe output within the
sample. Transcripts counts that are negative after background cor-
rection are set to 1. Each sample is thennormalized for RNA content
by adjusting the counts to the geometric mean of 15 housekeeping
genes (Supplementary Table 2). Finally, the data were log2 trans-
formed. Full details of each step can be found in the supplementary
information of Waggott et al. [8]. Network data were designed
by association matrix and the graph file was created using Gephi.
Nodeswere aligned by Force Atlas algorithmand the centralitywas
calculatedby thebetweenness. Statistical analyseswereperformed
using Graphpad Prism version 5.0.
4. Results
4.1. Pathogen detection in NPAs by nCounter transcriptomics
The digital nCounter profiling technology captures and counts
specific nucleic acid molecules in a complex mixture [5]. Briefly,
unique pairs of capture and detection probes are designed against
each gene of interest. The capture probe consists of a sequence
complimentary to a target pathogen mRNA and a short common
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Fig. 2. nCounter profile of pathogen transcripts in nasopharyingeal aspirates (NPA) from patients with ARI.
NPA (n=4)was submitted toRNAextraction and, subsequently, to nCounter analysis for the detection of (A) Adenovirus (AV),Bocavirus (BoV),Coronavirus (CoV), Parainfluenza
virus (PIV), Respiratory Syncytial virus A and B (RSV A and B), Influenza virus A and B (IV A and B), Human metapneumovirus (hMPV) and Rhinovirus (RV). Data are shown
as the number of counts (transcripts), for each target. (B) Pooled NPA RNA (n=4) were hybridized alone (NPA) or in the presence of control viral RNA (NPA+ spiked viral
RNA). Black bars represent hybridization with control viral RNA alone. Data are shown as the mean number of counts (transcripts), for each target± SD. (C) Detection of
Chlamydophila pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Mycoplasma pneumoniae, Staphylococcus aureus and Streptococcus pneumoniae in each individual
NPA sample. Black bars reflect hybridization with control bacterial RNA (pooled). Data are shown as the number of counts (transcripts), for each target.
sequence coupled to an affinity tag (biotin). The reporter probe also
contains the complementary sequence but is coupled to a color-
coded tag, providing the detection signal. The color code in each
tag is unique, allowing the accurate discrimination of the differ-
ent targets, in a complex mixture. Capture and reporter probes are
mixed with total RNA in a single hybridization reaction, resulting
in the formation of tripartite structures (target bound to the spe-
cific reporter and captureprobes). Unhybridizedprobes arewashed
away and remaining complexes are exposed to streptavidin. Tar-
gets bound to the specific probes are immobilized on a solid surface
that is scanned; the unique reporter probe then identifies each tar-
get and the level of expression is measured by the digital readout
of transcript counts. The reaction occurs in the absence of nucleic
acid amplification and/or enzymatic reactions. To estimate target
concentration, nCounter uses a series of positive controls cover-
ing a range of known concentrations (0.1–100 fM, comparable to
0.2–200 copies per cell). Based on the counts obtained for these
known concentrations, the concentration of mRNA transcripts can
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be estimated. This estimate is done by plotting the counts obtained
for the positive controls versus the concentrations tested and by
fitting a regression line through the average (Fig. 1). The regression
line allows the quantification of mRNA transcript concentration.
The correlation between the counts for positive controls and the
concentrationwas 0.99 and 0.98 for the lower concentration range.
Next,we assessed thepotential of nCounter as a diagnostic tech-
nique forARI. Inpilot experiments,weusedRNAobtained fromNPA
of fourpatients and the set of probes custom-designed for detection
of viral [RV, RSVA-B, IV A-B, PIV (types 1 and 3), AV (types 2 and 5),
hMPV, BoV andCoV (229A andOC43)] and bacterial (S. pneumoniae,
H. influenzae, M. catarrhalis, S. aureus, C. pneumoniae, and M. pneu-
moniae) targets (SupplementaryTable1).Wedetected thepresence
ofAV, CoVandRSVB (Fig. 2A),whereasBoV, PIV, RSVA, IVA-B, hMPV
and RV were detected in none of the four samples initially tested.
Detection was also positive in NPA spiked with known viral RNA
(6.25–12.5–25ng), indicating absence of inhibitors in RNA isolated
from NPA (Fig. 2B). In addition, use of tRNA (an RNA carrier) to
ARI samples did not improve viral detection (Supplementary Fig.
1), confirming that even NPA containing low input RNA (<10ng) is
suitable. Bacterial RNA (H. influenzae, M. catarrhalis, M. pneumoniae,
S. aureus, and S. pneumoniae)was alsodetected inbothpatientsı´ and
control NPA (Fig. 2C).
For comparison purposes, we performed RSV A and B detection
by Real-Time PCR. Agreement between nCounter and Real-Time
PCR was 86.2% for RSVA (kappa=0.231) and 96.9% for RSVB
(kappa=0.82) (Table 1). RNA counts detected by nCounter were
significantly correlated to the number of copies detected by Real-
Time PCR for both RSVA (r=0.25, Spearman; p=0.049) and RSVB
(r=0.83; Spearman p=0.001).
Table 1
RSVA and RSVB agreement between Real Time PCR and nCounter results in NPA
samples from ARI patients.
nCounter Real-Time PCR
RSVA RSVB
Positive Negative Total Positive Negative Total
Positive, n 2 4 6 5 0 5
Negative, n 5 54 59 2 58 60
Total 7 58 65 7 58 65
4.2. Pathogen network in NPA samples of children with ARI
We then expanded nCounter analysis to a set of 61 randomly
selected NPA and included seven healthy control samples (Fig. 3).
Using this extended group, we detected RV (2% of samples), BoV
(3%), CoV (229E and OC43, 3%), IV A (3%), hMPV (5%), PIV (geno-
types 1 and 3, 21%) and RSV A and B (21%). In addition, detection
of DNA virus AV (types 2 and 5) was confirmed at the RNA level
in 10% of samples, indicating ongoing (intracellular) viral replica-
tion. Transcripts for C. pneumoniae, M. catarrhalis, M. pneumoniae
and S. pneumoniae were detected in 2, 3, 8 and 26% of samples,
respectively. H. influenzae and S. aureus transcripts were ubiqui-
tous (69 and 77% of samples, respectively) and were also detected
in healthy controls (28 and 100% of samples, respectively). Using
this data set, we observed bacterial presence in themajority of chil-
dren (55.1%),whereas in43.5%of children, bothvirusesandbacteria
were present (Fig. 4A). A low percentage of children (1.5%) pre-
sented viruses only. Upon observation of the number of transcripts
per type of pathogen (Fig. 4B), AV 2 and RSB (A and B) showed
Fig. 3. Heat map dendrogram of pathogen detection by nCounter in children with ARI.
RNA from ARI patients (n=61) and from healthy controls (n=7) were hybridized against probes for adenovirus (AV), Bocavirus (BoV), Coronavirus (CoV), Influenza virus (IV),
Human metapneumovirus (hMPV), parainfluenza virus (PIV), Rhinovirus (RV), Respiratory Syncytial Virus (RSV), C. pneumoniae, H. influenzae, M. catarrhalis, M. pneumoniae,
S. aureus and S. pneumoniae. Samples were clustered by complete linkage of spearman correlation and color intensity indicates probe counts in each sample. The processed
data were log2-transformed.
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Fig. 4. Microbe counts (transcripts) in NPA of children with ARI, determined by
nCounter.
(A) Chart showing the percentages of samples (n=61) presenting counts (tran-
scripts) for bacteria (blue), viruses (red) or both viruses and bacteria (green). (B)
Bar plot representing the mean number of counts (transcripts) detected for each
pathogen in NPA samples (n=61). Adenovirus (AV), Bocavirus (BoV), Coronavirus
(CoV), Influenza virus (IV), Human metapneumovirus (hMPV), parainfluenza virus
(PIV), Rhinovirus (RV), Respiratory Syncytial Virus (RSV), C.p, C. pneumoniae; Hi, H.
influenzae, M.c, M. catarrhalis; M.p, M. pneumoniae; S.a, S. aureus and S.p, S. pneumo-
niae.
the highest mean transcript numbers (>10.000), comparing the 61
samples. The mean number of transcripts detected for AV 5, BoV
and PIV 3 was <10.000. CoV (229E and OC43), IV (A and B), hMPV,
PIV 1 and RV presented the lowest mean number of transcripts
(≤1000). For bacteria, the mean transcript number of C. pneumo-
niae, across the 61 NPA samples, was comparable to that detected
for AV andRSV (∼10.000). For the other bacterial targets (H. influen-
zae, M. catarrhalis, M. pneumoniae, S. aureus and S. pneumoniae), the
mean number of transcripts was ≤1000.
Network analysis also revealed the complex interactions that
occur between individual viruses and bacteria detected in NPA
(Fig. 5). For example, the strongest links were observed for bacte-
ria: H. influenzae/S. aureus and, secondly, H. influenzae/S. aureus or
H. influenzae/S. pneumoniae. Comparing virus and bacteria, PIV1/H.
influenzae showed a strong interaction as did RSV (A and B)/S.
aureus. Of note, the interactions of CoV 229E were different from
those observed for CoV OC43.
5. Discussion
Our results demonstrate that nCounter is a robust medium-
throughput technique for detection of both viral and bacterial
RNA transcripts in ARI patients. The sensitivity and reproducibil-
ity of nCounter has already been compared with Openarray® [9],
Affymetrix microarray [10] and TaqMan PCR [5]. In the latter,
nCounter was equally reproducible and sensitive regarding detec-
tionofdifferentiallymodulatedgenes; however, nCounterdetected
low abundant transcripts, not detected by microarray. nCounter
was also successfully used for detection of pathogen RNA tran-
scripts in clinical samples [11], and an important advantage is
transcript detection without the need for purification or amplifi-
cation, yielding a rapid indicator of pathogen replication.
Transcriptomic profiling by nCounter allowed simultaneous
detection of both viral and bacterial transcripts in ARI patients.
We detected the presence of AV, BoV, CoV, IV, hMPV, PIV, RV
and RSVA-B, which are associated with respiratory tract infections
[1]. To our knowledge, this is the first description of detection of
a pathogenic DNA virus (Adenovirus type 2 and 5) at the RNA
level in clinical samples. In contrast to a standard DNA PCR, which
quantifies DNA in (mostly extracellular) viral particles, nCounter
enables demonstration of ongoing (intracellular) viral replication,
which we hypothesize to be more relevant to ARI pathogenesis.
We also, simultaneously detected transcripts for C. pneumoniae, M.
catarrhalis and S. pneumoniae, which are commonly isolated from
the respiratory tract [12], as is H. influenzae. We observed a good
agreement between Real-Time PCR and nCounter for RSV (A and
B) detection, reinforcing the possibility of using the latter as an
alternative method for pathogen detection. Of note, RSVA strains
present a high variability in the target used for detection (G pro-
tein domain) [13], also in Brazil [6], which could explain theweaker
correlation observed for nCounter and Real-Time PCR, as compared
to RSVB.
The healthy upper respiratory tract is colonized by commen-
sals and potential pathogens kept in check by the immune system.
There is evidence that viral respiratory infections can stimulate
an increase in bacterial load and this association can lead to sec-
ondary complications [14]. Preterm infants with RSV and bacterial
co-infection were hospitalized for longer periods and more fre-
quently admitted to the intensive care unit, compared to children
infected with RSV alone [15]. In our samples, the majority of ARI
patients presented H. influenzae and S. aureus, which, together
with S. pneumoniae and M. catarrhalis are the usual opportunis-
tic pathogens co-detected with RSV [16–18]. Indeed, transcripts
for all these agents were detected in our NPA samples from chil-
dren with ARI. Network analysis showed strong links between PIV
1 and H. influenzae and between RSV B and S. pneumoniae, for
example. Both S. pneumoniae [19] and RSV activate the inflam-
masome [20]; S. pneumoniae triggers NF-kB activation leading
to an inflammatory response whereas, RSV infection results in a
strong interferon response. The possible overlap between the sig-
naling pathways triggered by each pathogen may synergize and
amplify the inflammatory signal during co-infection. This exac-
erbated immune response could accentuate damage in situ and
increase morbidity. Given this scenario, knowing the effective
pathogen load, as shown here by nCounter, can contribute towards
understanding the contribution of each pathogen to disease sever-
ity. As a proof-of-principle, our group has already used nCounter
to simultaneously quantify both human and retroviral transcrip-
tomes; thus, revealing intact IFN signaling in HTLV-1 infection [21].
We conclude that nCounter can be used as an alternative
medium-throughput method to identify, in a single reaction, the
presence of multiple pathogens in NPA from ARI patients. Given
that respiratory infections are one of the most common reasons
for visits to physicians, improved diagnostic methods such as
nCounter can contribute to better patient management. More-
over, a transcriptomic approach involving pathogen detection, and
as discussed above, immune response transcripts will enable the
identification of biomarkers in ARI clinical samples, even those
presenting low RNA yield (10–50ng) such as NPA. This approach,
combined with long-term clinical follow-up, will increase our
understanding of ARI pathogenesis, disease progression (wheez-
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Fig. 5. Network distribution of viral and bacterial agents in NPA samples of children with ARI.
Each system component [Virus; RV, RSVA-B, IV A-B, PIV (types 1 and 3), AV (types 2 and 5), hMPV, BoV and CoV (229A and OC43) and bacteria (S. pneumoniae, H. influenzae,
M. catarrhalis, S. aureus, C. pneumoniae and M. pneumoniae) is indicated by a blue or red node, respectively] and is a partner of the network. Each line is a link between two
nodes and its color represents interactions with similar category circles (blue or red) or with a different category (grey). The width of each line is a measure of the strength
of the link between two nodes. The circles are represented according to the ForceAtlas2 scheme.
ing, asthma) and, more importantly, provide an evidence-based
approach for the targeted and rational use of antibiotics in pediatric
ARI.
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